Nuzenio

Meet Primary End

Meet Primary End news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLiveHCPLive · Fri, 07 Aug 2026 23:10:36 GMTAltimmune’s Investigational Therapy For Alcohol Use Disorder Meets Primary Endpoint – ALT Stock Jumps 10% - StocktwitsStocktwits · Fri, 07 Aug 2026 14:25:47 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLiveHCPLive · Fri, 07 Aug 2026 14:06:13 GMTBemnifosbuvir/Ruzasvir Meets Primary Endpoint in Phase 3 HCV Trial - Contagion LiveContagion Live · Mon, 03 Aug 2026 12:06:41 GMTRitlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials - Dermatology TimesDermatology Times · Thu, 30 Jul 2026 13:32:39 GMTInnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study - GlobeNewswireGlobeNewswire · Mon, 27 Jul 2026 10:50:10 GMTMapLight Therapeutics Says Phase 2 Schizophrenia Trial Meets Primary Endpoint - MoomooMoomoo · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 23:10:36 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLive
Fri, 07 Aug 2026 14:25:47 GMTAltimmune’s Investigational Therapy For Alcohol Use Disorder Meets Primary Endpoint – ALT Stock Jumps 10% - Stocktwits
Fri, 07 Aug 2026 14:06:13 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLive
Mon, 03 Aug 2026 12:06:41 GMTBemnifosbuvir/Ruzasvir Meets Primary Endpoint in Phase 3 HCV Trial - Contagion Live
Thu, 30 Jul 2026 13:32:39 GMTRitlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials - Dermatology Times
Mon, 27 Jul 2026 10:50:10 GMTInnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study - GlobeNewswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Meet Primary End.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.